Sagit Manor Sells Shares of NYAX

On June 26, 2026, Sagit Manor, the Chief Financial Officer of NYAX, sold 79 shares of the company. The sale, which was not part of a pre-planned trading program, totaled $5,057.58 at an average price of $64.02 per share.

Insider Buying and Selling at Nayax Ltd.

Several other executives at NYAX also sold shares around the same time. On June 29, Aaron Samuel Greenberg, the Chief Strategy Officer, sold 54 shares at $63.85. Oren Tepper, Chief Revenue Officer, sold 74 shares at $63.80 and an additional 57 shares on June 26 at $64.02. Michal Sever, the Chief Marketing Officer, sold 35 shares at $63.89, and Carly Lisanne Furman, CEO of NYAX North America, sold 109 shares at $64.42. Sagit Manor sold another 214 shares at $63.86.

Other Institutional Activity in NYAX

Institutional investors have shown varied interest in NYAX. Y.D. More Investments Ltd increased its holdings by 25,694 shares, bringing its total to 865,171 shares valued at approximately $48.4 million, a 3.1% increase. Capital World Investors reduced its stake by 84,259 shares to 715,793 shares, valued at $40.5 million, reflecting a 10.5% decrease. Altravue Capital, LLC significantly boosted its holdings by 319,861 shares, ending with 549,574 shares worth about $30.8 million, marking a 139.2% increase. Vanguard Capital Management LLC opened a new position with 410,361 shares valued at $23.1 million. Meanwhile, Clal Insurance Enterprises Holdings Ltd cut its stake by 275,355 shares to 384,524 shares, a 41.7% decrease, with a value of $21.5 million.

Nayax Ltd. Stock Up 25.5%

Shares of NYAX traded near $64.07 on Tuesday. The company has seen active interest from institutional investors, as reflected in recent trading activities. The stock's performance and institutional movements suggest a dynamic interest in its market position.

Analysts Set New Price Targets

UBS maintained its hold rating on NYAX, setting a price target of $75 on June 24, 2026. Previously, on May 13, 2026, UBS had set a target of $68. Keefe, Bruyette & Woods also maintained a hold rating with a $75 target on the same date. The consensus among analysts remains cautious with a hold recommendation, reflecting a balanced view of NYAX's potential.

Bottom Line

Sagit Manor's sale of NYAX shares is part of a broader trend of insider sales at the company, though it doesn't necessarily indicate a negative outlook. Institutional investors are actively adjusting their positions, with some increasing their stakes while others trim them. Analysts remain cautious, maintaining hold ratings with targets suggesting modest upside potential. As always, these insider and institutional activities provide a snapshot of confidence in the company's future, though they are not predictive of future stock performance.